ALPHA PARADIGM PARTNERS, LLC Halozyme Therapeutics, Inc. Transaction History

ALPHA PARADIGM PARTNERS, LLC portfolio value:

$913,000
portfolio value

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 23.09K shares 913K $39.54 23.09K